PDT For Induction Therapy For Head And Neck Cancer

NCT07214987 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

26

Enrollment

OTHER

Sponsor class

Conditions

Squamous Cell Carcinoma
Head and Neck Cancer Squamous Cell Carcinoma
Head and Neck Cancer

Interventions

DRUG: Toripalimab-tpzi
DRUG: Cisplatin
DRUG: Docetaxel

Sponsor

Massachusetts General Hospital

Collaborators

[object Object]